BioPharma Dive November 22, 2024
Jonathan Gardner and Ned Pagliarulo

A prolific medical research and author, Marty Makary criticized the FDA and CDC for their decision-making during the pandemic, although he describes himself as pro-vaccine.

President-elect Donald Trump on Friday named Johns Hopkins University surgeon Marty Makary to lead the Food and Drug Administration, choosing a prolific medical researcher who bucked consensus on the necessity of frequent vaccination during the COVID-19 pandemic.

As FDA commissioner, Makary would oversee an agency of some 18,000 employees who assess new drugs and devices, review the performance of approved medicines and monitor food quality and safety. The agency typically evaluates and makes decisions on more than 50 new drug and biological products each year.

Makary, whose specialty is pancreatic surgery, is something of a...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Congress / White House, FDA, Govt Agencies
Supporting the Development of Drugs for Rare Diseases — The Importance of Regulatory Transparency
Opinion: To fight for those with rare diseases, Trump must reform and modernize the FDA thoughtfully
5 Rare Diseases That Now Have Their First FDA-Approved Treatments
FDA’s Recent Guidance on Accelerated Approval and Implications for Rare Diseases
This Bill Could Make It Legal for AI to Prescribe Medicine

Share This Article